We are live on ! Find out more
GWPH

GW Pharmaceuticals Plc American Depositary Shares
GWPH

Delisted

GWPH was delisted on the 4th of May, 2021.

Back to rankings

299 hedge funds and large institutions have $3.08B invested in GW Pharmaceuticals Plc American Depositary Shares in 2020 Q2 according to their latest regulatory filings, with 48 funds opening new positions, 66 increasing their positions, 99 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more capital invested

Capital invested by funds: $2.23B → $3.08B (+$844M)

30% more first-time investments, than exits

New positions opened: 48 | Existing positions closed: 37

3% more funds holding

Funds holding: 289 → 299 (+10)

0% more funds holding in top 10

Funds holding in top 10: 6 → 6 (0)

33% less repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 99

33% less call options, than puts

Call options by funds: $57M | Put options by funds: $85.6M

Holders
299
Holders Change
+10
Holders Change %
+3.46%
% of All Funds
6.13%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.12%
New
48
Increased
66
Reduced
99
Closed
37
Calls
$57M
Puts
$85.6M
Net Calls
-$28.6M
Net Calls Change
+$20.4M

Top Buyers

Rank Fund Capital Flow
1
Capital World Investors
Capital World Investors
California
+$82.3M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
+$49.9M
3
Norges Bank
Norges Bank
Norway
+$18.2M
4
Bank of New York Mellon
Bank of New York Mellon
New York
+$13.5M
5
BG
Bellevue Group
Switzerland
+$11.2M

Top Sellers

Rank Fund Capital Flow
1
Victory Capital Management
Victory Capital Management
Texas
-$83.8M
2
MGIM
M&G Investment Management
United Kingdom
-$31.2M
3
Franklin Resources
Franklin Resources
California
-$31.1M
4
BBA
Baker Bros. Advisors
New York
-$21.1M
5
Holocene Advisors
Holocene Advisors
New York
-$18.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
LWA
276
Lowe Wealth Advisors
Maryland
$3K – – –
PA
277
Parallel Advisors
California
$3K – – –
VRM
278
Vectors Research Management
New York
$3K – – –
KFS
279
Kelly Financial Services
Massachusetts
$2.09K -$3.18K -28 -62%
PFBT
280
Parkside Financial Bank & Trust
Missouri
$2K -$1.59K -14 -44%
CCM
281
Covington Capital Management
California
$2K – – –
FCM
282
Firestone Capital Management
Florida
$2K – – –
GI
283
Gradient Investments
Minnesota
$2K – – –
MF
284
Manchester Financial
California
$2K – – –
ME
285
McIlrath & Eck
Washington
$2K – – –
TL
286
TrueWealth LLC
Georgia
$2K +$2.27K +20 New
CHC
287
City Holding Co
West Virginia
$1K – – –
PP
288
Pacifica Partners
Canada
$1K – – –
WAS
289
Winch Advisory Services
Wisconsin
$1K – – –
WR
290
Watson Rebecca
$1K +$567 +5 New
Bessemer Group
291
Bessemer Group
New Jersey
$1K +$681 +6 New
BFIM
292
Beese Fulmer Investment Management
Ohio
$1K +$1.14K +10 New
PA
293
Perennial Advisors
New York
$1K +$1.36K +12 New
TI
294
tru Independence
Oregon
$12 +$11.3K +100 New
Holocene Advisors
295
Holocene Advisors
New York
– -$18.1M -206,743 Closed
Millennium Management
296
Millennium Management
New York
– -$4.39M -50,165 Closed
PF
297
Phoenix Financial
Israel
– -$4.28M -50,000 Closed
Hudson Bay Capital Management
298
Hudson Bay Capital Management
Connecticut
– -$2.63M -30,000 Closed
CIBC World Market
299
CIBC World Market
Ontario, Canada
– -$1.88M -21,442 Closed
ECM
300
Endurant Capital Management
California
– -$1.48M -16,890 Closed
10 11
12
13 14

GWPH Hedge Fund Activity: Q2 2020 in Review

299 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) for Q2 2020, worth a combined $3.08B — up 38% from $2.23B a quarter earlier.

Buyers outnumbered sellers: 48 funds opened new GWPH positions and 37 closed out — a net gain of 11 holders — while 66 added to existing stakes and 99 trimmed.

The largest buyer was Capital World Investors, adding an estimated $82.3M. The largest seller was Victory Capital Management, cutting an estimated $83.8M.

  • 299 institutional investors held GW Pharmaceuticals Plc American Depositary Shares (GWPH) as of Q2 2020, up from 289 in Q1 2020.
  • Funds reported $3.08B of GW Pharmaceuticals Plc American Depositary Shares stock for Q2 2020, up 38% quarter-over-quarter.
  • 48 funds opened new GW Pharmaceuticals Plc American Depositary Shares positions in Q2 2020 and 37 closed out, a net change of +11 holders.
  • The largest GW Pharmaceuticals Plc American Depositary Shares buyer in Q2 2020 was Capital World Investors, an estimated $82.3M added.
  • The largest GW Pharmaceuticals Plc American Depositary Shares seller in Q2 2020 was Victory Capital Management, an estimated $83.8M sold.

Based on aggregated 13F filings for Q2 2020.